Results 91 to 100 of about 5,013 (193)

Prophylactic and therapeutic vaccines for Japanese cedar pollinosis

open access: yesFolia Pharmacologica Japonica, 2010
スギ花粉症は日本固有の季節性アレルギー疾患で,くしゃみや鼻炎症状,結膜炎症状を特徴とする.その患者数は3000万人を超えたとも言われている.症状の軽い人は,抗ヒスタミン薬や抗ロイコトリエン薬の服用で症状をある程度コントロールすることができるものの,中重症度の多くの患者さんは,既存の対症療法に満足していないのが実情で,根本的な治療法が求められている.しかしながら,現在唯一の治療法はスギ花粉エキスを皮下投与する減感作療法であるが,十分に普及していない.その主たる理由して,長期間の通院が必要であることや作用機序が十分に解明されていないこと,さらにはアナフィラキシーを誘発する危険性を回避するために,高容量のスギ花粉エキスを注射できないことが挙げられる.我々は,現状の問題を解決する新たな予防・治療法として ...
openaire   +3 more sources

Characterizing the Flavor of New Zealand Native Plants Using Consumer‐Derived Attributes and Gas Chromatography–Mass Spectrometry

open access: yesJournal of Food Science, Volume 91, Issue 3, March 2026.
ABSTRACT Understanding the flavor properties of Aotearoa‐New Zealand native plants is essential for their successful incorporation into foods and beverages. This study characterized the flavor of six edible plant species using consumer sensory evaluation and gas chromatography–mass spectrometry (GC–MS) of volatile compounds.
Carolina E. Realini   +6 more
wiley   +1 more source

New Allergens Approved by the WHO/IUIS Allergen Nomenclature Sub‐Committee in 2021–2024 and Their Significance for Future Diagnostics, Regulation, and Research. An EAACI Task Force Report

open access: yesAllergy, Volume 81, Issue 3, Page 684-699, March 2026.
ABSTRACT The WHO/IUIS Allergen Nomenclature Sub‐Committee is an international body of experts that maintains the systematic nomenclature of allergenic proteins by assigning official names to newly identified allergens submitted by researchers. Here, we summarize the data on new allergens approved between 2021 and 2024.
Christian Radauer   +12 more
wiley   +1 more source

Tensile Examination and Strength Evaluation of Latewood in Japanese Cedar. [PDF]

open access: yesMaterials (Basel), 2022
Takahashi A   +3 more
europepmc   +1 more source

Pathogenesis and Treatment of Japanese Cedar Pollenosis

open access: yesPractica Oto-Rhino-Laryngologica, 2008
Allergic rhinitis is one of the most common allergic inflammation affecting 10-25 percent of the world's population, and its prevalence has increased over the last decade. Allergic rhinitis is not a life-threatening disease, but its persistent symptoms disturb patient's daily life. Moreover, it could be a risk factor to elongate infective inflammations
openaire   +2 more sources

Complement Factor H Is an Early Predictive Biomarker of the Therapeutic Efficacy of Sublingual Immunotherapy for Japanese Cedar Pollinosis. [PDF]

open access: yesPathogens, 2022
Yoneda R   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy